Denosumab In Mumbai

MOQ10 Unit/Units

Dosage FormLiquid

Origin of MedicineIndia

Drug TypeInjection

Physical FormLiquid

DosageAs per suggestion

Storage InstructionsDry Place

MOQ10 Unit/Units

Pacakaging (Quantity Per Box)1 Pre-Filled Syringe per box

Dosage FormInjection

Origin of MedicineBiotechnology (r-DNA origin)

IndicationTreatment of osteoporosis in postmenopausal women and men at increased risk of fracture, bone loss due to hormone ablation, prevention of skeletal-related events

Salt CompositionDenosumab 60mg/mL

Drug TypeInjection

MOQ1 Pack/Packs

IndicationAs directed by physician

Dosage FormAs directed by the physician

Drug TypeInjection

IngredientsDENOSUMAB 60 MG

Physical FormLiquid

FunctionAnti-Bacterial

MOQ100 Piece/Pieces

ColorClear

Equipment TypeOther

ConditionNew

PortableYes

DisposableYes

Wall MountedNo

MOQ2

Dosage FormLIQUID

Origin of MedicineINDIA

Packaging TypePFS

Pacakaging (Quantity Per Box)1

Brand NameOLIMAB

Drug TypeInjection

MOQ1 Pack/Packs

Origin of MedicineIndia

Drug TypeInjection

Physical FormLiquid

Dosage120 mg /1.7 ml

Dosage GuidelinesAs per suggestion

Storage InstructionsDry place

MOQ10 Pack/Packs

OriginIndia

Salt CompositionDenosumab

Dosage FormInjection

Fermentation SmellNormal Smell

Storage InstructionsCold & Dry

Shelf Life24 Months

MOQ1 Piece/Pieces

Origin of MedicineIndia

Salt CompositionDenosumab

Drug TypeInjection

Physical FormLiquid

DosageAs per Prescription

Suitable ForAdults

MOQ100 Number

OriginIndia

Dosage FormLiquid

IngredientsNatural Yeast

Fermentation SmellSlight Smell

Storage InstructionsRoom Temperature

Shelf Life4-5 Months

MOQ10 Unit/Units

Dosage FormLiquid

OriginIndia

Fermentation SmellNormal Smell

Storage Instructions(20AdegC to 25AdegC or 68AdegF to 77AdegF)

Shelf Life24-36 Months

MOQ10 Vial/Vials

Salt CompositionDenosumab

Brand NameRozel

OriginMumbai, Maharashtra, India

Dosage FormLiquid

Drug TypeOther

IngredientsRozel 60mg Injection is a high-quality anticancer medication widely used in the treatment of various solid tumors. It contains Denosumab 60 mg, a monoclonal antibody that works by inhibiting bone resorption and reducing skeletal-related events in patients with cancer involving the bones. It is administered under the supervision of a qualified healthcare professional.Key BenefitsHelps prevent bone complications in cancer patientsReduces risk of fractures and bone painImproves bone strength by inhibiting osteoclast activityProven efficacy in oncology-related bone disordersCompositionActive Ingredient: Denosumab 60 mgDosage Form: InjectionTherapeutic UsesBone metastasis associated with solid tumorsPrevention of skeletal-related events in cancer patientsManagement of cancer-induced bone lossAdministrationFor subcutaneous injection onlyTo be administered by a medical professional as prescribedStorage InstructionsStore at 2 C to 8 C (Refrigerated)Do not freezeProtect from lightPrecautionsPrescription drug; use only under medical supervisionNot recommended during pregnancy unless advised by a physicianRegular monitoring of calcium levels is recommendedPackagingSingle-use vial / prefilled syringe (as available)

MOQ1 Piece/Pieces

Life Span24 months

IndicationBone metastasis in cancer

Salt CompositionDenosumab 120mg

Packaging TypeVial

Dosage FormInjection

Pacakaging (Quantity Per Box)1 vial